MODICA is a privately held Polish biotechnology company founded in 2022 with the mission to establish a unique technology platform for simulation, monitoring and controlling of bioprocesses to unlock the connectivity potential.
MODICA’s technologies enable the high level of bioprocess automation and efficient process development.
MODICA’s powerful technologies are being used to develop a range of therapeutic and novel compounds and molecules.
MODICA was recognized as the most innovative biotech startup from Central Europe by CE BioPhorum, in April 2023.
MODICA’s leadership represents diverse backgrounds and experiences. With collective experience from the biotech, engineering, and IT sectors, along with scientific knowledge and business acumen, are taking the company to the next stage in its development.
Board member
lukas@modica.bio
Community & PR
klaudia@modica.bio